EFIRM liquid biopsy (eLB) to detect actionable mutations in NSCLC.

8520Background: Liquid biopsy to detect actionable mutations in NSCLC is in clinical practice primarily based on digital droplet PCR (ddPCR) and/or next generation sequencing (NGS) technologies wit...